Ava

$HIMS This peptide thing could be huge. I guess we wait until July. They already bought a factory to make them though and that’s pretty big news.

$SOUN I haven't posted this public service announcement in a while: Remember to only listen to the bears if you hate money, and they have absolute contempt for it. Beauty.

$IONQ WOW! Nice to have the old action back. I missed it. Congrats to the 40 strike call buyers. I'll be enjoying a buffet today, featuring BBQ 🐻. It's been a while. Where's Max Pain? I want to give him a call...lol

$IBRX Was just watching News Nation and Coumo and Spicer were on and they were defending PSS that nothing he said on the podcast should of been given a warning. Just about 12:15 on the show.

$ONDS Hold fast guys. This had to close the gap around 9.60 before reversing upward. Grin and bear it. We're going up soon. Patience. If you don't have patience, take a tranquilizer.

$SENS Doesn't look like it. Float short is greater than 13% of the float and the increasing of borrowing cost means tutes are slowly calling back their shares which means they want it to go up soon.

$MAAS "Full-stack AI" is a compelling hook, but fast integration and monetization are critical. Markets will soon shift focus to margins, revenue, and cash burn. $SNSE $AVGO $NUAI $ORCL $IBRX

UBS holds a position of 600,000 shares in $GRRR, appearing on the board just above Gorilla. This significant institutional ownership highlights a major stakeholder in the company.

Micron is completely sold out through 2027. This represents a once-in-a-lifetime opportunity. I am allocating all available capital into $MU.

$IBRX remains in a strong long-term trend despite recent short-selling pressure. A significant reversal is expected soon.

$MAAS focuses on efficient charging, intelligent control, and layered safety. This robust combination addresses essential market demands as mobile charging solutions continue to scale globally.

$MAAS $ASTS mobile charging robots are built for real-world use. Featuring 150kWh LFP batteries and integrated BMS safety systems, these are ready-to-deploy solutions rather than just concepts.

Dr. Patrick's update on $IBRX is significant. This randomized study of 366 patients provides the robust statistics the FDA requires. If the power holds, FDA approval appears highly likely.

$MAAS peak vs off-peak electricity represents an untapped profit engine. Those managing energy scheduling will control the next critical infrastructure layer.

Top 20 wide-moat stocks down 20%+ from highs: $MCO $SHW $CTAS $ISRG $AVGO $CDNS $IDXX $META $SPGI $TMO $TDG $MSFT $NFLX $SNPS $MELI $RMS $RACE $DHR $LVMH $FICO. Many now trade at attractive NTM P/E levels.

$MAAS reflects inefficiency: empty chargers in some areas while others face long queues. Optimizing resource distribution is essential for better infrastructure.

Charging efficiency, not batteries, remains the primary bottleneck for EV growth. $MAAS

$META is trading under $600 per share, bringing its forward P/E ratio to 19.98. How much lower do you expect the valuation to drop?

I hold 43,000 shares of $IBRX at a $3.60 average. The company’s global potential is staggering, and I expect it to reach $400. Diamond hands for the long term.

The market logic seems broken as $IBM drops while Anthropic is treated like the new S&P 500 benchmark. Current valuations feel completely disconnected from reality.